CRP and endothelial dysfunction: In cardiovascular and inflammatory diseases, suPAR often exhibits smaller absolute differences than traditional biomarkers (e.g., CRP or troponins) but retains prognostic value due to its pathophysiological specificity for immune activation and endothelial dysfunction [14,19].